期刊文献+

新辅助化疗对局部晚期宫颈癌组织微血管密度和微淋巴管密度的影响 被引量:2

The effects of neoadjuvant chemotherapy on microvessel density and lymphatic microvessel density in locally advanced uterine cervical cancer
原文传递
导出
摘要 目的探讨新辅助化疗对局部晚期宫颈癌组织微血管密度(MVD)和微淋巴管密度(LMVD)的影响。方法选择50例行新辅助化疗患者的宫颈癌组织及20例正常宫颈组织,采用免疫组织化学方法测定MVD和LMVD,分析新辅助化疗对其的影响。结果新辅助化疗前宫颈癌组织MVD、LMVD分别为(29.21±3.69)%、(24.15±4.12)%,均明显高于正常宫颈组织的(9.11±2.81)%、(5.59-1-1.08)%,差异有统计学意义(P〈0.05);新辅助化疗后宫颈癌组织MVD、LMVD分别为(21.14±2.11)%、(17.24±2.21)%,均较新辅助化疗前明显降低,差异有统计学意义(P〈0.05)。术后生存时间多血管组(MVD〉21%,20例)、多淋巴管组(LMvD〉17%,23例)分别为(22.10±6.25)、(20.10±4.12)个月,明显低于少血管组(MVD≤21%,29例)和少淋巴管组(MVD≤17%,26例)的(33.45±8.11)、(30.16±5.77)个月(P〈O.05)。MVD和LMVD与患者术后生存时间呈负相关(r=-0.216,P=0.001;r=-0.126,P=0.009)。结论新辅助化疗能有效降低局部晚期宫颈癌组织MVD和LMVD,对于改善宫颈癌患者的近期疗效和远期生存有一定的作用。 Objective To investigate the effects of neoadjuvant chemotherapy (NACT) on microvessel desity (MVD) and lymphatic microvessel density (LMVD) in locally advanced uterine cervical cancer (UCC). Methods Fifty specimens of UCC tissues who received NACT and twenty specimens of normal uterine cervical tissues were collected. The MVD and LMVD were examined by immunohistochemistry, and the clinical impact of NACT was analyzed. Results The MVD and LMVD in UCC tissues before NACT [(29.21 ± 3.69)% and (24.15 ±4.12)% ] were significantly higher than those in normal cervical tissues [ (9.11 ± 2.81 )% and (5.59 ± 1.08 )% ] (P 〈 0.05 ). The MVD and LMVD were significantly decreased after NACT [ (21.14 ± 2.11 )% and ( 17.24 ± 2.21 )% ] than before NACT(P 〈 0.05 ). The postoperative survival time in multiple vessels group (MVD 〉 21% ,20 cases) and lymph vessels group (LMVD 〉 17% ,23 cases) were significantly shorter than that in less vessels group (MVD ≤21% ,29 cases ) and lymph vessels group (LMVD ≤17% ,26 cases ) [ (22.10 ± 6.25 ) mouths vs. (33.45 ± 8.11 ) months, (20.10 ±4.12) months vs. (30.16 +5.77) months,P 〈0.05]. There was a negative correlation between the MVD and LMVD and postoperative survival times (r =-0.216,P = 0.001 ;r =-0.126,P = 0.009 ). Conclusion NACT can be helpful to reduce the MVD and LMVD,and has some effect on improving short-term treatment effect and long-term survivals.
作者 周三琴
出处 《中国医师进修杂志》 2013年第3期24-26,共3页 Chinese Journal of Postgraduates of Medicine
关键词 宫颈肿瘤 药物疗法 微血管密度 微淋巴管密度 Uterine cervical neoplasms Drug therapy Microvessel density Lymphaticmicrovessel density
  • 相关文献

参考文献12

  • 1Miyahara M, Tanuma J, Sugihara K, et al. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer,2007,110 (6) : 1287-1294.
  • 2Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995,36(2) : 169-180.
  • 3单金海,成波,谭波,张爱民,刘利维,韩瑞发.肾细胞癌组织中内皮抑素、MVD表达变化及意义[J].山东医药,2011,51(22):19-21. 被引量:1
  • 4陈递林,彭芝兰,王和,姚先莹.卵巢浆液性肿瘤中的血管生成研究[J].医学研究通讯,2005,34(8):16-18. 被引量:5
  • 5Cox G, Walker RA, Andi A, et al. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer. Lung Cancer, 2000,29(3 ) : 169-177.
  • 6杨昆宪,唐晓丹,迟昆萍.新辅助化疗AC或TA方案可降低乳腺癌MVD但不影响P-gp、GST-π的表达[J].肿瘤,2008,28(10):882-884. 被引量:3
  • 7Choi WW, Lewis MM, Lawson D,et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma:cor- relation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol,2005,18( 1 ) : 143-152.
  • 8Benedetti-Panici P,Greggi S,Colombo A,et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer:results from the Italian multicenter randomized study. J Clin Oncol,2002,20( I ): 179-188.
  • 9王军,徐伏兰.伊立替康联合奈达铂新辅助化疗治疗局部晚期子宫颈癌近期疗效分析[J].中国医药,2012,7(9):1155-1156. 被引量:5
  • 10Chen H,Liang C,Zhang L,et al. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage I B2- I1 B) cervical cancer:randomized study. Gyneeol Oneol, 2008,110(3 ) : 308-315.

二级参考文献42

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2王林波,姜支农,宋向阳,谢树夺,金梅,曹江.新辅助化疗对乳腺癌耐药基因表达的影响[J].中华普通外科杂志,2006,21(4):260-262. 被引量:3
  • 3王敏,陈桂林,黄燕玲.局部晚期宫颈癌新辅助化疗的近期疗效分析[J].实用肿瘤学杂志,2007,21(4):368-369. 被引量:3
  • 4Mankoff DA,Thompson JA,Gold P,et al.Identification of IL-2 induced complete response in metastatic RCC by FDG PET despite radiogra-phic evidence suggesting persistent tumor[J].AJR Am J Roentgend,1997,169(4):1049-1050.
  • 5Robson CJ,Churchill BM,Anderson W.The results of radical nephrectomy for renal cell carcinoma[J].J Urol,1969,101(3):297-301.
  • 6Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumor[J].Breast Cancer Res Treat,1996,36(2):169-180.
  • 7Guenther U,Herbst H,Bauer M,et al.Collagen type ⅩⅧ/endostatin is differentially expressed in primary and metastatic colorectal cancers and ovarian carcinomas[J].Br J Cancer,2001,85(10):1540-1545.
  • 8Feldman AL,Pak H,Yang JC,et al.Serum Endostatin levels are elevated in patients with soft tissue sarcoma[J].Cancer,2001,91(8):1525-1529.
  • 9Morimoto T,Aoyagi M,Tamaki M,et al.In creased levels of tissue Endostatin in human malignant gliomas[J].Clin Cancer Res,2002,8(9):2933-2938.
  • 10Dhanabal M,Ramchandran R,Waterman MJ,et al.endostatin induces endothelial cell apoptosis[J].J Biol Chem,1999,274(17):11721-11726.

共引文献12

同被引文献24

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部